Similar articles

• Hormone therapy use and outcomes in the Women's Health Initiative trials--reply.

  Manson JE, Chlebowski RT, Aragaki AK. Manson JE, et al. JAMA. 2014 Jan 22-29;311(4):417-8. doi: 10.1001/jama.2013.285163. JAMA. 2014. PMID: 24449323 No abstract available.
• The Women's Health Initiative--a victory for women and their health.

  Nabel EG. Nabel EG. JAMA. 2013 Oct 2;310(13):1349-50. doi: 10.1001/jama.2013.278042. JAMA. 2013. PMID: 24084919 No abstract available.
• Menopausal hormone therapy has risks and benefits during the intervention and poststopping phase.

  Warren MP. Warren MP. Evid Based Med. 2014 Jun;19(3):105. doi: 10.1136/eb-2013-101656. Epub 2014 Feb 3. Evid Based Med. 2014. PMID: 24492931 No abstract available.
• Postmenopausal hormone replacement therapy in the light of the women's health initiative trial.

  van der Mooren MJ, Kenemans P. van der Mooren MJ, et al. Eur J Obstet Gynecol Reprod Biol. 2003 Apr 25;107(2):123-4. doi: 10.1016/s0301-2115(02)00413-x. Eur J Obstet Gynecol Reprod Biol. 2003. PMID: 12648855 Review. No abstract available.
• Alternative hormone replacement regimens: is there a need for further clinical trials?

  Welty FK. Welty FK. Curr Opin Lipidol. 2003 Dec;14(6):585-91. doi: 10.1097/00041433-200312000-00006. Curr Opin Lipidol. 2003. PMID: 14624135 Review.